|Brand||Revolade Tablets 25mg and 50mg|
|Product Name:||Revolade Tablets 25mg and 50mg|
|Strength:||25mg and 50mg|
In the event of overdose, platelet counts may increase excessively and result in thrombotic/thromboembolic complications. In case of an overdose, consider oral administration of a metal cation-containing preparation, such as calcium, aluminium, or magnesium preparations to chelate eltrombopag and thus limit absorption.
Precaution And Warning:
Combination with direct acting antiviral agents
Safety and efficacy have not been established in combination with direct acting antiviral agents approved for treatment of chronic hepatitis C infection.
Risk of hepatotoxicity:Revolade administration can cause abnormal liver function. In the controlled clinical studies in chronic ITP with eltrombopag, increases in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and bilirubin were observed